Literature DB >> 2616436

Ventricular fibrillation due to lithium withdrawal--an interaction with chlorpromazine?

R N Stevenson1, C Blanshard, D L Patterson.   

Abstract

We report a case of primary ventricular fibrillation following withdrawal of lithium in a patient concurrently taking chlorpromazine. A potentially important drug interaction is discussed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2616436      PMCID： PMC2429573          DOI： 10.1136/pgmj.65.770.936

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  11 in total

1.  A case of lithium-chlorpromazine interaction.

Authors:  R Yassa
Journal:  J Clin Psychiatry       Date:  1986-02       Impact factor: 4.384

2.  Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs.

Authors:  N O Fowler; D McCall; T C Chou; J C Holmes; I B Hanenson
Journal:  Am J Cardiol       Date:  1976-02       Impact factor: 2.778

3.  Cardiovascular complications in young patients taking psychotropic drugs. A preliminary report.

Authors:  C S Alexander; A Niño
Journal:  Am Heart J       Date:  1969-12       Impact factor: 4.749

4.  Fending off the potassium pushers.

Authors:  J P Kassirer; J T Harrington
Journal:  N Engl J Med       Date:  1985-03-21       Impact factor: 91.245

5.  Neurotoxicity with combined administration of lithium and a neuroleptic.

Authors:  R Prakash; S Kelwala; T A Ban
Journal:  Compr Psychiatry       Date:  1982 Nov-Dec       Impact factor: 3.735

6.  Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics.

Authors:  G Addonizio
Journal:  J Clin Psychopharmacol       Date:  1985-10       Impact factor: 3.153

7.  The prolonged QT interval--a frequently unrecognized abnormality.

Authors:  R A Kenny; R Sutton
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

8.  The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram.

Authors:  J R Huston; G E Bell
Journal:  JAMA       Date:  1966-10-03       Impact factor: 56.272

9.  Effect of lithium on gastric emptying and absorption of oral chlorpromazine.

Authors:  L Rivera-Calimlim
Journal:  Psychopharmacol Commun       Date:  1976

10.  Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.

Authors:  L Rivera-Calimlim; H Nasrallah; J Strauss; L Lasagna
Journal:  Am J Psychiatry       Date:  1976-06       Impact factor: 18.112
View more
  1 in total

Review 1.  Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs.

Authors:  Candace S Brown; Richard G Farmer; Judith E Soberman; Samantha F Eichner
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.